Teva Pharmaceuticals has reached a settlement with most US states alleging it participated in a sprawling conspiracy to inflate the prices of more than 80 generic drugs. The US District Court for the District of Connecticut said on Monday that Teva and the states had reached “an agreement in principle” and agreed to stay all deadlines involving the defendant. Also in Tipline, Ep...
Click on the "Follow" button below and you'll get the latest news from Global Competition Review via email, mobile or you can read them on your personal news page on this site.
You can unsubscribe anytime you want easily.
You can also choose the topics or keywords that you're interested in, so you receive only what you want.
Global Competition Review title: Global Competition Review